top headlines
Evonik is investing US$100 million over the next five years [...]
SGD Pharma has reported a 27% reduction in Scope 1 [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Autolomous and Cellular Origins have integrated their platforms to create [...]
Alamar Biosciences has launched what it describes as the first [...]
Bio-Rad Laboratories has launched a portfolio of Vericheck ddPCR kits [...]
Genespire and researchers at the San Raffaele Telethon Institute for [...]
FORE Biotherapeutics has completed target enrolment in the primary central [...]
A peer-reviewed study published in Therapeutic Innovation & Regulatory Science [...]
